Abstract

HTA32 When Should the Conduct of RWE Studies Be Prioritized for Reimbursement: Insights from Canadian and Global Stakeholders

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Dynamics of Stakeholders’ Implications in the Institutionalization of the CSR Field in France and in the United States
Emma Avetisyan ... Michel Ferrary
Journal of business ethics : JBE | VOL. 115
Emma Avetisyan, et. al.Emma Avetisyan ... Michel Ferrary
30 Jun 2012
Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
Dominique Guillaume ... Rupali Limaye
Human Vaccines & Immunotherapeutics | VOL. 18
Dominique Guillaume, et. al.Dominique Guillaume ... Rupali Limaye
07 Dec 2022
Facilitative governance: Transforming global health through complexity theory
Just Haffeld
Global Public Health | VOL. 7
Just HaffeldJust Haffeld
16 Jan 2012
Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin – January 29–30, 2015
Ajoke Sobanjo-Ter Meulen ... Keith P Klugman
Vaccine | VOL. 33
Ajoke Sobanjo-Ter Meulen, et. al.Ajoke Sobanjo-Ter Meulen ... Keith P Klugman
24 Aug 2015
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
Christine Le Clainche ... Jean-Christophe Vergnaud
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Christine Le Clainche, et. al.Christine Le Clainche ... Jean-Christophe Vergnaud
06 Jul 2024
Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey
Gordon G Liu ... Huajie Jin
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Gordon G Liu, et. al.Gordon G Liu ... Huajie Jin
06 Jul 2024
Valuation of Multi-Dimensional Health States With a Bolt-On: Is There a Shortcut?
Zhihao Yang ... Nan Luo
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Zhihao Yang, et. al.Zhihao Yang ... Nan Luo
06 Jul 2024
View more papers